BECTON, DICKINSON AND COMPANY for BECTON DICKINSON AND COMPANY
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues related to corporate income tax deferral H.R. 3590, The Patient Protection and Affordable Care Act, Issues related to medical device tax H.R.3962, Affordable Health Care for America Act, Issues related to medical device tax H.R. 4872, Health Care Reconciliation Bill, Issues related to medical device tax
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANTHONY LAKAVAGE | — |
| PAUL SELTMAN | — |
| ELIZABETH WOODY | — |
Health Issues HCR
H.R. 3590 (P.L. 111-148), Patient Protection and Affordable Care Act, Issues related to healthcare reform, medical device tax, prevention of healthcare-associated infections, value-based purchasing, Medicare clinical laboratory fee schedule adjustments H.R.3962, Affordable Health Care for America Act, Issues related to healthcare reform, medical device tax, prevention of healthcare-associated infections, value-based purchasing, Medicare clinical laboratory fee schedule adjustments H.R.759, Food and Drug Administration Globalization Act of 2009, Issues related to import safety S.882, Drug and Device Accountability Act of 2009, Issues related to import safety Issues related to pandemic planning
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANTHONY LAKAVAGE | — |
| PAUL SELTMAN | — |
| ELIZABETH WOODY | — |
Medicare/Medicaid MMM
H.R.3962, Affordable Health Care for America Act, Issues related to healthcare reform, prevention of healthcare-associated infections, value-based purchasing, Medicare clinical laboratory fee schedule adjustments H.R. 3590, The Patient Protection and Affordable Care Act, Issues related to healthcare reform, prevention of healthcare-associated infections, value-based purchasing, Medicare clinical laboratory fee schedule adjustments
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANTHONY LAKAVAGE | — |
| PAUL SELTMAN | — |
| ELIZABETH WOODY | — |
Budget/Appropriations BUD
Issues related to safe injection practices funding Issues related to global health funding Issues related to NIH funding Issues related to pandemic funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH WOODY | — |
Labor Issues/Antitrust/Workplace LBR
Issues relating to needlestick safety
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH WOODY | — |
Medical/Disease Research/Clinical Labs MED
H.R. 3590, The Patient Protection and Affordable Care Act, Issues related to Medicare clinical laboratory fee schedule adjustments H.R.3962, Affordable Health Care for America Act, Issues related to Medicare clinical laboratory fee schedule adjustments
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANTHONY LAKAVAGE | — |
| PAUL SELTMAN | — |
| ELIZABETH WOODY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.